Evidence map›Paper›PMID 35139665›Full record

ArticleHypertension (Dallas, Tex. : 1979)2022

Aortic Pulse Wave Velocity as Adjunct Risk Marker for Assessing Cardiovascular Disease Risk: Prospective Study.

Carlos A Valencia-Hernández, Joni V Lindbohm, Martin J Shipley, Ian B Wilkinson, Carmel M McEniery, Sara Ahmadi-Abhari, Archana Singh-Manoux, Mika Kivimäki, Eric J Brunner

Open access · bronzeAbstract read
In one paragraph

Article in Hypertension (Dallas, Tex. : 1979), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Pulse Wave Velocity: Is It Time to Reduce the Cutoff Point?Arquivos brasileiros de cardiologia · 2023
    Article
  18. Article
  19. Age and vascular aging: an unexplored frontier.Frontiers in cardiovascular medicine · 2023
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 5 countries.

Carlos A Valencia-HernándezResearch Department of Epidemiology and Public Health, University College London, London, United Kingdom (C.A.V.-H., J.V. L., M.J.S., A.S.-M., M.K., E.J.B.).ORCID 0000-0002-7596-4846
Joni V LindbohmResearch Department of Epidemiology and Public Health, University College London, London, United Kingdom (C.A.V.-H., J.V. L., M.J.S., A.S.-M., M.K., E.J.B.).
Martin J ShipleyResearch Department of Epidemiology and Public Health, University College London, London, United Kingdom (C.A.V.-H., J.V. L., M.J.S., A.S.-M., M.K., E.J.B.).
Ian B WilkinsonClinical Pharmacology Unit, University of Cambridge, Cambridge, United Kingdom (I.B.W., C.M.M.).
Carmel M McEnieryClinical Pharmacology Unit, University of Cambridge, Cambridge, United Kingdom (I.B.W., C.M.M.).ORCID 0000-0003-3636-0705
Sara Ahmadi-AbhariAgeing Epidemiology Research Unit, Imperial College London, United Kingdom (S.A.-A.).ORCID 0000-0003-4440-4050
Archana Singh-ManouxResearch Department of Epidemiology and Public Health, University College London, London, United Kingdom (C.A.V.-H., J.V. L., M.J.S., A.S.-M., M.K., E.J.B.).
Mika KivimäkiResearch Department of Epidemiology and Public Health, University College London, London, United Kingdom (C.A.V.-H., J.V. L., M.J.S., A.S.-M., M.K., E.J.B.).ORCID 0000-0002-4699-5627
Eric J BrunnerResearch Department of Epidemiology and Public Health, University College London, London, United Kingdom (C.A.V.-H., J.V. L., M.J.S., A.S.-M., M.K., E.J.B.).ORCID 0000-0002-0595-4474
Public Health England · GBUniversity of Cambridge · GBImperial College London · GBInserm · FRUniversity of Helsinki · FI

Funding

Socioeconomic gradient in CHD in early old ageR01HL036310 · NHLBI · UNIVERSITY OF LONDON · PI KIVIMAKI, MIKA J, MARMOT, MICHAEL G · 1986 to 2012
$3.1M
Education, socioeconomic status and Aging: transitions from multimorbidity to functional limitations and mortalityR01AG056477 · NIA · UNIVERSITY COLLEGE LONDON · PI KIVIMAKI, MIKA J, SINGH-MANOUX, ARCHANA · 2018 to 2022
$2.8M
Role of mid- and late-life risk factors in social inequalities in Alzheimer's Disease and Related DementiasRF1AG062553 · NIA · INSERM PARIS 5 · PI KIVIMAKI, MIKA J, SINGH-MANOUX, ARCHANA · 2019 to 2019
$1.5M
Biotechnology and Biological Sciences Research Council BRC-1215-20014British Heart Foundation RG/13/2/30098British Heart Foundation RG/16/11/32334Medical Research Council MR/K013351/1Medical Research Council MR/R024227/1NHLBI NIH HHS R01 HL036310NIA NIH HHS R01 AG056477NIA NIH HHS RF1 AG062553
6 · The paper itself

Abstract

backgroundAortic pulse wave velocity is a noninvasive measure of aortic stiffness and arterial aging. Its current value in cardiovascular risk estimation practice is unknown. We aimed to establish whether aortic pulse wave velocity identified individuals with higher risk of incident major adverse cardiovascular events and improved performance of the American Heart Association/American College of Cardiology atherosclerotic cardiovascular disease risk score.

methodsThis prospective analysis included 3837 Whitehall II cohort participants screened in 2008 to 2009, and followed for 11.7 years (mean=10.3, SD=1.81), without history of stroke, myocardial infarction, or coronary heart disease.

resultsMean age of the sample was 65.0 years (SD=5.6), 2831 participants (73.8%) were male and mean atherosclerotic cardiovascular disease risk score was 13.8%. At the end of follow-up, 411 individuals (10.7%) had suffered a major cardiovascular event. Those in the highest aortic pulse wave velocity quartile were at high risk (hazard ratio, 2.99 [95% CI, 2.25-3.97]) and reached the threshold for statin medication (7.5% risk) after 5 years whereas others reached it after 10 years (difference

conclusionsOur results show that aortic stiffness predicted major adverse cardiovascular events in a cohort of elderly individuals, improving the performance of a widely used cardiovascular disease risk estimator. Aortic pulse wave velocity measurement is scalable, radiation-free, and easy to perform. Further studies on its applicability in cardiovascular disease risk assessment in primary care settings are needed.

Indexed as

Cardiovascular DiseasesVascular StiffnessAgedAortaFemaleHumansMaleProspective StudiesPulse Wave AnalysisRisk Factorsagingarteriosclerosisatherosclerosisblood pressurecholesterolhypertension

Identifiers

PMID35139665
PMCPMC9148390
OpenAlexW4211043269

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.